[Clinical experiences with the vascular action of dihydroergocristine].
D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy*; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy*; D004088:Dihydroergotoxine / Q000008:administration & dosage / Q000627:therapeutic use*; D004877:Ergoloid Mesylates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007269:Injections, Intra-Arterial; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007383:Intermittent Claudication / Q000188:drug therapy*; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012881:Skin Temperature / Q000187:drug effects
D004088:Dihydroergotoxine; D004877:Ergoloid Mesylates
Esperienze cliniche sull'azione vascolare della diidroergocristina